The sacral chordoma margin.

[1]  Juha Kiiski,et al.  Clinical results and quality of life after reconstruction following sacrectomy for primary bone malignancy. , 2018, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.

[2]  D. Campanacci,et al.  Surgical Treatment of Sacral Chordoma: En Bloc Resection with Negative Margins is a Determinant of the Long-Term Outcome. , 2018, Surgical technology international.

[3]  L. Mariani,et al.  Imatinib and everolimus in patients with progressing advanced chordoma: A phase 2 clinical study , 2018, Cancer.

[4]  Y. Lim,et al.  Clinical outcome of proton therapy for patients with chordomas , 2018, Radiation oncology journal.

[5]  J. Debus,et al.  Sacral insufficiency fractures after high-dose carbon-ion based radiotherapy of sacral chordomas , 2018, Radiation Oncology.

[6]  Kei Yamada,et al.  Outcomes of Patients With Primary Sacral Chordoma Treated With Definitive Proton Beam Therapy. , 2017, International journal of radiation oncology, biology, physics.

[7]  Seiichi Matsumoto,et al.  Analysis of the Infiltrative Features of Chordoma: The Relationship Between Micro-Skip Metastasis and Postoperative Outcomes , 2018, Annals of Surgical Oncology.

[8]  Z. Gokaslan,et al.  Comprehensive biomechanical analysis of three reconstruction techniques following total sacrectomy: an in vitro human cadaveric model. , 2017, Journal of neurosurgery. Spine.

[9]  Eva Ardanaz,et al.  Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study. , 2017, The Lancet. Oncology.

[10]  J. Blay,et al.  Advanced chordoma treated by first-line molecular targeted therapies: Outcomes and prognostic factors. A retrospective study of the French Sarcoma Group (GSF/GETO) and the Association des Neuro-Oncologues d'Expression Française (ANOCEF). , 2017, European Journal of Cancer.

[11]  S. Kunakornsawat,et al.  What Are the Functional Outcomes After Total Sacrectomy Without Spinopelvic Reconstruction? , 2017, Clinical orthopaedics and related research.

[12]  Wei Guo,et al.  What Are the Conditional Survival and Functional Outcomes After Surgical Treatment of 115 Patients With Sacral Chordoma? , 2017, Clinical orthopaedics and related research.

[13]  P. A. Gardner,et al.  Best practices for the management of local-regional recurrent chordoma: a position paper by the Chordoma Global Consensus Group , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[14]  A. Niemierko,et al.  Updated Outcome and Analysis of Tumor Response in Mobile Spine and Sacral Chordoma Treated With Definitive High-Dose Photon/Proton Radiation Therapy. , 2017, International journal of radiation oncology, biology, physics.

[15]  Xiaohui Niu,et al.  Recurrence and survival factors analysis of 171 cases of sacral chordoma in a single institute , 2017, European Spine Journal.

[16]  Z. Gokaslan,et al.  Soft Tissue and Bone Defect Management in Total Sacrectomy for Primary Sacral Tumors: A Systematic Review With Expert Recommendations , 2016, Spine.

[17]  C. Bettegowda,et al.  Management of Locally Recurrent Chordoma of the Mobile Spine and Sacrum: A Systematic Review , 2016, Spine.

[18]  R. Orecchia,et al.  Dose prescription in carbon ion radiotherapy: How to compare two different RBE-weighted dose calculation systems. , 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[19]  N. Araki,et al.  Carbon Ion Radiation Therapy for Unresectable Sacral Chordoma: An Analysis of 188 Cases. , 2016, International journal of radiation oncology, biology, physics.

[20]  P. Casali,et al.  Sacral Chordoma: Long-term Outcome of a Large Series of Patients Surgically Treated at Two Reference Centers , 2016, Spine.

[21]  T. Delaney,et al.  Sacral Insufficiency Fractures are Common After High-dose Radiation for Sacral Chordomas Treated With or Without Surgery , 2016, Clinical orthopaedics and related research.

[22]  C. Zoccali,et al.  Residual neurological function after sacral root resection during en-bloc sacrectomy: a systematic review , 2016, European Spine Journal.

[23]  Christine S. M. Lau,et al.  Pediatric Chordomas: A Population-Based Clinical Outcome Study Involving 86 Patients from the Surveillance, Epidemiology, and End Result (SEER) Database (1973-2011) , 2016, Pediatric Neurosurgery.

[24]  Kimberly-Anne Tan,et al.  Prognostic Factors in the Operative Management of Sacral Chordomas. , 2015, World neurosurgery.

[25]  G. Nielsen,et al.  High-dose proton-based radiation therapy in the management of spine chordomas: outcomes and clinicopathological prognostic factors. , 2015, Journal of neurosurgery. Spine.

[26]  P. Ruggieri,et al.  Prognostic factors in surgical resection of sacral chordoma , 2015, Journal of surgical oncology.

[27]  T. Witham,et al.  Soft-tissue reconstruction after total en bloc sacrectomy. , 2015, Journal of neurosurgery. Spine.

[28]  K. Herfarth,et al.  Carbon ion beam treatment in patients with primary and recurrent sacrococcygeal chordoma , 2015, Strahlentherapie und Onkologie.

[29]  C. Zoccali,et al.  The surgical neurovascular anatomy relating to partial and complete sacral and sacroiliac resections: a cadaveric, anatomic study , 2015, European spine journal.

[30]  S. Stacchiotti,et al.  Building a global consensus approach to chordoma: a position paper from the medical and patient community. , 2015, The Lancet. Oncology.

[31]  M. Fehlings,et al.  Surgical treatment of sacral chordoma: prognostic variables for local recurrence and overall survival , 2015, European Spine Journal.

[32]  B. Yeap,et al.  Long‐term results of Phase II study of high dose photon/proton radiotherapy in the management of spine chordomas, chondrosarcomas, and other sarcomas , 2014, Journal of surgical oncology.

[33]  R. Sasaki,et al.  Particle therapy using carbon ions or protons as a definitive therapy for patients with primary sacral chordoma. , 2014, The British journal of radiology.

[34]  M. McDonald,et al.  Clinical Investigation : Central Nervous System Tumor Proton Therapy for Reirradiation of Progressive or Recurrent Chordoma , 2013 .

[35]  D. Kirsch,et al.  Definitive High-Dose Photon/Proton Radiotherapy for Unresected Mobile Spine and Sacral Chordomas , 2013, Spine.

[36]  K. Schaller,et al.  Incidence and relative survival of chordomas , 2013, Cancer.

[37]  Wei Guo,et al.  One-Stage Total En Bloc Sacrectomy: A Novel Technique and Report of 9 Cases , 2013, Spine.

[38]  Roberto Orecchia,et al.  Dose prescription in carbon ion radiotherapy: a planning study to compare NIRS and LEM approaches with a clinically-oriented strategy , 2012, Physics in medicine and biology.

[39]  M. Durante,et al.  Mapping of RBE-weighted doses between HIMAC- and LEM-Based treatment planning systems for carbon ion therapy. , 2012, International journal of radiation oncology, biology, physics.

[40]  S. Waikakul,et al.  Wide resection of sacral chordoma via a posterior approach , 2012, International Orthopaedics.

[41]  Francesca Albertini,et al.  Spot-scanning-based proton therapy for extracranial chordoma. , 2011, International journal of radiation oncology, biology, physics.

[42]  R. Imai,et al.  Clinical outcome of sacral chordoma with carbon ion radiotherapy compared with surgery. , 2011, International journal of radiation oncology, biology, physics.

[43]  P. Ruggieri,et al.  Surgical Margins and Local Control in Resection of Sacral Chordomas , 2010, Clinical orthopaedics and related research.

[44]  B. Yeap,et al.  Phase II study of high-dose photon/proton radiotherapy in the management of spine sarcomas. , 2009, International journal of radiation oncology, biology, physics.

[45]  T. Delaney,et al.  Sacral chordomas: Impact of high-dose proton/photon-beam radiation therapy combined with or without surgery for primary versus recurrent tumor. , 2006, International journal of radiation oncology, biology, physics.

[46]  F. Sim,et al.  Operative management of sacral chordoma. , 2005, The Journal of bone and joint surgery. American volume.

[47]  L. Kindblom,et al.  Prognostic factors in chordoma of the sacrum and mobile spine , 2000, Cancer.

[48]  P. Michenet,et al.  Sacrococcygeal chordomas: potential role of high LET therapy. , 1998, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.